|
RAB8A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.522300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.877000E-03 |
| Normal-vs-Stage2 |
3.118800E-01 |
| Normal-vs-Stage3 |
3.640400E-02 |
| Normal-vs-Stage4 |
4.295600E-01 |
| Stage1-vs-Stage2 |
5.762600E-01 |
| Stage1-vs-Stage3 |
3.52340000000506E-05 |
| Stage1-vs-Stage4 |
7.273000E-01 |
| Stage2-vs-Stage3 |
1.451640E-02 |
| Stage2-vs-Stage4 |
9.569600E-01 |
| Stage3-vs-Stage4 |
4.194000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.416000E-02 |
| Normal-vs-AfricanAmerican |
5.388000E-01 |
| Normal-vs-Asian |
4.563400E-01 |
| Caucasian-vs-AfricanAmerican |
7.562000E-02 |
| Caucasian-vs-Asian |
3.306300E-02 |
| AfricanAmerican-vs-Asian |
1.413620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.444000E-02 |
| Normal-vs-Female |
6.852200E-01 |
| Male-vs-Female |
4.671700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.478100E-02 |
| Normal-vs-Extreme_Weight |
9.043900E-02 |
| Normal-vs-Obese |
4.903600E-01 |
| Normal-vs-Extreme_Obese |
3.194600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.068000E-01 |
| Normal_Weight-vs-Obese |
2.258800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.720800E-01 |
| Extreme_Weight-vs-Obese |
2.794200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.632400E-01 |
| Obese-vs-Extreme_Obese |
5.253800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.337000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.230800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.464400E-03 |
| Normal-vs-Age(81-100Yrs) |
4.483500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.560600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.481860E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.640400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.995200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.077360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.514800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.351900E-02 |
| Normal-VS-Type2 PRCC |
5.149400E-01 |
| Normal-VS-KIRP CIMP |
3.739000E-01 |
| Normal-VS-Unclassified PRCC |
3.696800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.264000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.435710E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.265800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.851020E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.288600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.438620E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.910600E-01 |
| Normal-vs-N1 |
1.668020E-01 |
| Normal-vs-N2 |
1.192460E-02 |
| N0-vs-N1 |
3.953800E-02 |
| N0-vs-N2 |
1.587600E-01 |
| N1-vs-N2 |
2.545600E-02 |
|
|
